SKK
HBIO icon

Shepherd Kaplan Krochuk’s Harvard Bioscience HBIO Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,200
Closed -$31K – 231
2017
Q2 		$31K Sell
1,200
-1,050
-47% -$26K 0.02% 238
2017
Q1 		$59K Sell
2,250
-1,175
-34% -$33.8K 0.03% 238
2016
Q4 		$104K Buy
+3,425
New +$87.1K 0.03% 223

Other funds holding HBIO

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPC
Glacier Peak Capital Bellevue, Washington $96.2M AUM 0.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
FP
Foundry Partners Minneapolis, Minnesota $1.89B AUM 9.84% 1-Year Est. Return

Shepherd Kaplan Krochuk's HBIO Position: Q3 2017 in Review

Shepherd Kaplan Krochuk sold out of Harvard Bioscience (HBIO) in Q3 2017, closing a stake of 1,200 shares — an estimated $31K sold.

Shepherd Kaplan Krochuk first reported a position in HBIO in Q4 2016 and held it in 3 quarters. The position peaked at $104K in Q4 2016. 53 funds tracked by Wall St. Rank hold HBIO as of Q3 2017.

  • Shepherd Kaplan Krochuk reported no remaining Harvard Bioscience position as of Q3 2017 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 1,200 Harvard Bioscience shares in Q3 2017, an estimated $31K.
  • Shepherd Kaplan Krochuk first reported a position in Harvard Bioscience in Q4 2016 and held it in 3 quarters.
  • Shepherd Kaplan Krochuk's Harvard Bioscience position peaked at $104K in Q4 2016.
  • 53 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2017.

Based on Shepherd Kaplan Krochuk's 13F filing for Q3 2017, filed 14 Nov 2017.